24_10_Thermo_Channel_banner

COMMERCIALIZATION AND LOGISTICS

3:46 Thermo Screen splash
Singapore Single-Use Site Capacity Expansion

Thermo Fisher Scientific is expanding our single-use manufacturing network globally, an expansion site closer to Asia Pacific region

18:56 Enhancing AAV Purification In Gene Therapy Manufacturing
Enhancing AAV Purification In Gene Therapy Manufacturing

Review chromatography solutions for purifying multiple AAV serotypes, with specialists’ insights on bioprocessing and downstream optimization.

3:10 Louis Sacco
Expanding Manufacturing Of Purification Resins To Align With Customer Demands

Discover how scaling up processes and building out facilities has allowed for end-to-end solutions that meet customer requirements for both supply and quality in their production lines.

6:53 23_12_CGL_mRNA_Webinar_Seg05
Supply Chain And Operational Challenges Facing mRNA

Explore some of the biggest supply chain challenges facing mRNA cancer therapeutics and what short-term solutions may exist, starting with Chain of Custody/Chain of Identity.

5:02 Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities
Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities

Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.

6:10 23_07_CGL_COGS_Webinar_Seg06
Safety And Efficiency Of Source Material Collection

Expert CTO's detail how automation improves safety and efficiency when collecting source material.

43:42 Simple In-House Mycoplasma Testing Method
Simple In-House Mycoplasma Testing Method For Regulatory Expectations And Rapid, Confident, And Actionable Results

In this webinar, we present an overview of worldwide regulatory guidance for mycoplasma testing, as well as a mycoplasma testing method that has been accepted by regulatory authorities worldwide across various therapeutic modalities.

9:07 24_04_CGL_1920x1080p_Seg4
Defining The CMC / Clinical Relationship For Allogeneic Cell Therapies

During this segment, Nguyen and Wagner define why the relationship between CMC and Clinical is so critical, and they also explain what a mutually beneficial partnership between CMC and Clinical looks like.

11:39 23_12_CGL_mRNA_Webinar_Seg06
mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A

During our Cell & Gene Live, mRNA For Cancer Immunotherapy 2024 Outlook, our expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.

20:50 Scalable Purificaiton Of In Vitro Transcribed mRNA
Scalable Purification Of In Vitro Transcribed mRNA

Learn more about how affinity-based mRNA chromatography resin facilitates the purification and isolation of mRNA from in vitro transcription (IVT) manufacturing processes.

5:05 Perfusion Hardware Needs
Perfusion: Hardware Needs

In this video, we will discuss cell retention mechanisms, pumps, and intensification challenges in the perfusion process.

59:51 GettyImages-597971944-viral-vector-AAV-adeno-associated-virus
Upstream To Downstream: A Comprehensive Approach To AAV Production

How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.

27:51 Thermo Roundtable screenshot
Quality Roundtable: Optimizing Biologics Manufacturing Processes With Raw Materials

Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.

59:11 Manufacturing Considerations For Viral & Non-Viral Platform Selection
Manufacturing Considerations For Viral & Non-Viral Platform Selection

In this webinar, a panel of experts spanning the lentiviral vector, exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.

1:22 CTS Detachable Dynabeads
An Active Release Mechanism For Magnetic Separation And Cell Isolation

Discover an innovative active release solution that will serve autologous and allogeneic processes to the benefit of cell therapy patients.

10:27 23_09_CGL_ViralVector_Webinar_1920x1080_Seg06
Scaling Viral Vectors

Industry experts cover the high operational costs associated with viral vectors, along with the challenge presented by their shot shelf life and scalability.

28:28 Supporting Development Of mRNA Therapeutics By Enabling Commercial-Scale
Supporting Development Of mRNA Therapeutics By Enabling Commercial-Scale mRNA Purification

Discover the next generation of scalable affinity capture for high-quality mRNA purification. Learn how a simple, reliable binding mechanism can maximize efficiency and simplify your manufacturing process.

1:47 CTS DynaCellect Magnetic Separation System Uninstalling Bead Removal Kit
CTS DynaCellect Magnetic Separation System Uninstalling Bead Removal Kit

Safely remove the bead removal kit from the CTS DynaCellect Magnetic Separation System. This video shows you how to remove the cassette and fluid lines.

15:32 Cell And Gene Therapy Innovations
Cell And Gene Therapy Innovations

This interview with a pharmaceutical analytics expert discusses key insights into advances in cell and gene therapy and the strategies used to support customers in improving their therapeutic development.

1:59 A CDMO Perspective Bioprocess Automation And Data Management
A CDMO Perspective: Bioprocess Automation And Data Management

Watch this video to understand data management and process automation challenges across single-use bioprocessing applications from a CDMO leader, Paul Jorjorian, VP and GM of Pharma Services at Thermo Fisher Scientific.

1:02 Process Liquids And Buffers Offering
Process Liquids And Buffers Offering

Whether you are a researcher, scientist, or industry professional, this video will provide valuable insights into our large volume liquids manufacturing capabilities.

3:45 23_09_CGL_ViralVector_Webinar_1920x1080_Seg02
Manufacturing Hurdles With Viral Vectors

With a wide range of viral vector-based drugs already approved, viral vectors are expected to remain the primary delivery mechanism for the foreseeable future. However, as the demand for viral vectors increases, addressing the challenges related to their manufacture and s...

1:28 TruBio Software Performing A 2-Point Calibration
Master The 2-Point Calibration Process To Maintain Data Integrity

Ensure accurate sensor readings with an innovative software by mastering the 2-point calibration process. Learn more about how and why regular calibration supports data integrity and compliance.

14:27 Optimization Of Anion Exchange Purification
Optimization Of Anion Exchange Purification For The Large-Scale Production Of Plasmid DNA

In this webinar, we discuss pDNA purification, including how to identify optimal conditions for various chromatography media and optimize recovery and impurity removal.

40:39 GettyImages-1170605838 quality
Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

3:47 Mary Fitzgibbon
Ensuring Quality, Driving Customer Confidence

How does quality assurance help drive scientific progress? A 30-year veteran shares her story of supporting customer needs and the development of groundbreaking new therapeutics.

0:43 Dynacellect Cinematic Overview
CTS DynaCellect Cinematic Overview

Achieve high cell purity and recovery with an automated, closed magnetic separation system. Learn how this technology helps increase robustness, minimize failures, and streamline cell therapy manufacturing.

6:22 23_07_CGL_COGS_Webinar_Seg02
Technology Needs For Automated Manufacturing

Investigate the importance of technology as it relates to automation and standardization within cell therapy manufacturing. The panelists in this discussion cover solutions and services needed for process automation in CGT.

0:58 Introducing trubio
A Robust, Future-Ready Solution That Adapts To Your Needs

Explore a future-ready solution that features advanced automation, intuitive design, and scalable solutions to streamline your bioprocessing workflows and prepare your operations for future growth.

2:30 Cell Therapy Bioprocessing Workflow Cinematic
Cell Therapy Bioprocessing Workflow Cinematic

Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype for scalable, effective autologous and allogeneic therapies.